Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

6.440
+0.0701.10%
Volume:313.07M
Turnover:2.03B
Market Cap:120.82B
PE:30.80
High:6.720
Open:6.720
Low:6.370
Close:6.370
Loading ...

Sino Biopharmaceutical Stock Falls 2.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
08 Jul

Inventiva SA Announces $10 Million Milestone Payment from CTTQ for Lanifibranor Clinical Progress in MASH Treatment

Reuters
·
08 Jul

Sino Biopharmaceutical Stock Falls 1.8% in Hong Kong

Dow Jones
·
07 Jul

One Sino Biopharmaceutical Insider Has Reduced Their Stake

Simply Wall St.
·
05 Jul

Sino Biopharmaceutical Stock Rises 2.8% in Hong Kong, Outperforms Competitors

Dow Jones
·
04 Jul

BRIEF-Sino Biopharmaceutical Says Recombinant Human Coagulation Factor Viia N01 Approved By NMPA

Reuters
·
03 Jul

Sino Biopharm Gets China Nod to Market Hemophilia Drug

MT Newswires Live
·
03 Jul

Sino Biopharmaceutical's Anqixin® Approved for Marketing in China, Offering New Hemophilia Treatment Option

Reuters
·
03 Jul

Sino Biopharmaceutical - Recombinant Human Coagulation Factor Viia N01 for Injection Approved by Nmpa

THOMSON REUTERS
·
03 Jul

Sino Biopharmaceutical Stock Advances 1.3% in Hong Kong

Dow Jones
·
02 Jul

Sino Biopharmaceutical Gets China Nod to Market Tumor Drug

MT Newswires Live
·
01 Jul

Sino Biopharmaceutical Limited Secures Regulatory Approval for Anlotinib Hydrochloride Capsules with Chemotherapy for First-Line Treatment of Soft Tissue Sarcoma

Reuters
·
30 Jun

Sino Biopharmaceutical - Anlotinib Hydrochloride Capsules With Chemotherapy for First-Line Treatment of Soft Tissue Sarcoma Approved for Marketing

THOMSON REUTERS
·
30 Jun

Sino Biopharmaceutical Stock Rallies 2.5% in Hong Kong, Outperforms Competitors

Dow Jones
·
27 Jun

BRIEF-Sino Biopharmaceutical Says LM-108 Included In Breakthrough Therapy Designation

Reuters
·
26 Jun

Sino Biopharmaceutical's LM-108 Monoclonal Antibody Enters Breakthrough Therapy Designation Process for Advanced Gastric Cancer Treatment in China

Reuters
·
26 Jun

Sino Biopharmaceutical - Lm-108 Included in Breakthrough Therapy Designation Process by Center for Drug Evaluation of Nmpa

THOMSON REUTERS
·
26 Jun

Ludwig Enterprises Inc. Appoints Garth Lees-Rolfe as New Independent Director

Reuters
·
26 Jun

Sino Biopharmaceutical Limited Presents Rovadicitinib Data at European Hematology Association Congress

Reuters
·
18 Jun

Sino Biopharm's Graft-Versus-Host Disease Treatment Included in China's Breakthrough THerapy Designation Process

MT Newswires Live
·
17 Jun